Iconix

Iconix developed integrated technologies to help identify novel therapeutic targets and predict potential efficacy, toxicity and other side-effects of drug candidates at the earliest stages of drug discovery. The company was a spin-out of Microcide Pharmaceuticals and was acquired by Entelos in August 2007.